Navigation Links
iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming
Date:7/7/2009

SOUTH SAN FRANCISCO, Calif. and BOSTON, July 8 /PRNewswire/ -- iZumi Bio, Inc. and Pierian, Inc. today announced they have merged to form a new company, iPierian, Inc. Building on the iZumi infrastructure and vision, the company is focused on the application of cellular reprogramming to change the paradigm of drug discovery. The scientific leadership of the company will accelerate the development of new therapeutics using induced pluripotent stem (iPS) cells for patients with difficult-to-treat diseases.

iPierian is rapidly building upon the experienced management and scientific team of iZumi, who have deep knowledge and experience in both stem cell technology and drug discovery. The company will be led by John P. Walker, currently the chief executive officer of iZumi. Dr. Berta Strulovici will head up research efforts as the chief technical officer of iPierian and Dr. Dushyant Pathak will lead the company's business development activities. Dr. Corey Goodman, recently the president of Pfizer's Biotherapeutics and Bioinnovation, an elected member of the U.S. National Academy of Sciences, and a board member of iZumi, will become chairman of the Board of Directors of iPierian.

The scientific founders of Pierian, Drs. George Daley, Douglas Melton and Lee Rubin, faculty members at Harvard University, will become actively involved in decisions regarding the scientific direction and research priorities for iPierian. Dr. Daley will co-chair the new Scientific Advisory Board (SAB) of iPierian together with Dr. Deepak Srivastava, director of the Gladstone Institute of Cardiovascular Disease and professor at the University of California San Francisco (UCSF). Dr. Corey Goodman will also sit on the company's SAB, and will be joined by a cadre of leading stem cell scientists.

"Since the inception of iZumi, we have built an organization and a platform of cellular programming as it applies to drug d
'/>"/>

SOURCE iZumi Bio, Inc.; Pierian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. The Gladstone Institutes and iZumi Bio Announce Broad Partnership in Regenerative Medicine and Cardiovascular Disease
2. iZumi Bio, Inc. Recruits Leading iPS Scientist, John Dimos, to Translate Stem Cell Breakthrough Into Patient Benefits
3. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
4. iZumi Bio Appoints Dr. Berta Strulovici as Chief Technology Officer and Dr. Dushyant Pathak as Vice President of Business Development
5. iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
9. ev3 and FoxHollow Announce Date for Special Meeting of FoxHollow Stockholders to Vote on Proposed Merger
10. IsoTis - Integra Merger
11. New Brunswick Scientific Completes Merger Transaction with Eppendorf

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...cBiotechLtd.(SVA),aleadingdeveloperandproviderofv...(JV)agreementtoestablishSinovac(Dalian)Vaccine,Tec...evelop,produce,andcommercializehuman-usevaccines.S...velopingandcommercializingworld-classvaccines;the,...acilitiesand,establishedoperatinginfrastructure. ,...
(Date:11/24/2009)..., Whether it,s CD packaging, containers or identi...ication) are increasingly finding their way into e...ts or goods and identify them automatically by rad... process the data contained in the label. Smart la...itions of up to 100 degrees Celsius. But at higher...
(Date:11/24/2009)...nt bank KTA Capital,s client Neuren Pharmaceutical...le note private placement with a U.S. institutiona...KTA Capital as Neuren,s exclusive placement agent ...PRWEB) November 23, 2009 -- The independent New Yo...ital") has announced that its client Neuren P...
(Date:11/24/2009)...-FirstCall/--deCODE,genetics,Inc.(Nasdaq: DCGN )to...tockMarketthattradinginthecompany,scommonstockwill...efiledwiththe,SecuritiesandExchangeCommission,whic...,unlessthecompanyfilesanappealtotheNasdaq,ListingQ...which,willstaythesuspensionanddelistingthroughthec...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
... and Athletes for Life Foundation announced that t... monitoring and screening at the Pontotoc,Technolo...gold medalist,Super Bowl champion, and a founder o... on June 24-25th to participate in a children,s he...ibrary of Medicine (NLM), a,division of the Nation...
...bsp.co.il/pressall.asp ) an Israeli company which ...nosis and monitoring of Ischemic Heart,Disease, an... in a private,funding round, that included existin...tors., BSP developed the HyperQ(TM), a cutting-ed...t and risk free cardiac monitoring for broad,popul...
...ted,growth in biotechnology innovation, targeted t... built significant traction in the past year in,te...eloitte study released,today at the 2008 BIO Inter...the Deloitte report support the need to measure,in...t of six biotechnology,innovations measured, the s...
Other Biology Technology:Signalife Announces AFL Joins NIH Education Program 2Signalife Announces AFL Joins NIH Education Program 3BSP Raises $2.6 Million Dollars From Private Investors 2In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 2In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 3In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 4In a Year of Unprecedented Growth for Biotechnology Innovation, Targeted Therapies Gain Most Significant Traction, According to New Deloitte Study 5
(Date:11/24/2009)...teries from collapsing have been true life-savers....needed -- once the arteries are strengthened, they...oice but to leave them in place. , Prof. Meital ...iomedical Engineering has developed a new patent-p...y,re needed, then dissolves. , "Our new composit...
(Date:11/24/2009)... of debate. A high-profile study a few years ago s...carbon from trees and leaves, evidence for a very ...systems. , But new research from the University ... Algae provide a much richer diet for fish and oth...his week in the Proceedings of the National Acade...
(Date:11/23/2009)... Applied mathematicians dissected the morphology ...cteristic long leaf with a saddle-like arc midsect...e simple cause of the lily,s fan-like shapeelastic...tial growthwas revealed by using an equally simple...ng, a postdoctoral student at Harvard,s School of ...
Breaking Biology News(10 mins):A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 1Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 2Boo 21 New Jersey Cosmetic Dentist Offering Cash for Candy This Halloween 26amp 3B 238211 3B and Giving Back to Our Soldiers Oversees 60169 3Schulman Associates IRB Establishes an Institutional Review Board in Canada 14618 1Schulman Associates IRB Establishes an Institutional Review Board in Canada 14618 23SBio Inc to Report 2009 Third Quarter Earnings on November 12 2009 14616 13SBio Inc to Report 2009 Third Quarter Earnings on November 12 2009 14616 2
... San Antonio Researchers are closer to developing...n, according to a study published this week in the..., online Early Edition. Karl Klose, director of t...ases (STCEID) at The University of Texas at San An...rchers at the Burnham Institute for Medical Resear...
...National economies are driven by the automobile, e...ds of millions of people take their cars to visit ...arket. , The total outlay for building roads amou...-hours. Miklos Szilagyi of the University of Arizo...esources, a serious producer of pollution, congest...
...Researchers at the National Institute of Environme... Institutes of Health, and Duke University have di... after exposure to ozone, a common urban air pollu...also able to identify several ways to stop the air...potential new targets for drugs which may eventual...
Other Biology News:Defectors take the car, cooperators go by bus 2Research finds new cause of ozone wheezing and potential treatments 2
Mechanical Cell Strain Instrument ST-160 Microscope Mountable from B-Bridge International
...tion is a post-translational modification that pla...uding immune regulation, inflammation, cell-to-cel...gy has developed two lectin based Glycoprotein Iso...Agglutinin (WGA), that allow isolation of glycopro...
...fers maleimide activated carrier proteins to simpl...mject Maleimide Activated Carrier Proteins are com...th a heterobifunctional cross-linker (Sulfo-SMCC)....eactive carrier protein. Thus allowing the maleim...
BD Falcon TufRol Cell Culture Flask, 25 cm2 from BD Biosciences - Discovery Labware
Biology Products: